NO872683L - Fremgangsmte for fremstilling av difenylazometinderivater - Google Patents
Fremgangsmte for fremstilling av difenylazometinderivaterInfo
- Publication number
- NO872683L NO872683L NO872683A NO872683A NO872683L NO 872683 L NO872683 L NO 872683L NO 872683 A NO872683 A NO 872683A NO 872683 A NO872683 A NO 872683A NO 872683 L NO872683 L NO 872683L
- Authority
- NO
- Norway
- Prior art keywords
- formula
- compound
- group
- ethanol
- mixture
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 150000001875 compounds Chemical class 0.000 claims description 24
- -1 2-pyridinyl Chemical group 0.000 claims description 15
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 6
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 239000012965 benzophenone Substances 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- CRZDNISJUXVSKX-UHFFFAOYSA-N 1h-imidazol-2-ylmethanamine Chemical compound NCC1=NC=CN1 CRZDNISJUXVSKX-UHFFFAOYSA-N 0.000 claims description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 159000000000 sodium salts Chemical class 0.000 claims description 2
- 239000013067 intermediate product Substances 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 14
- 208000025865 Ulcer Diseases 0.000 description 8
- 231100000397 ulcer Toxicity 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 238000010898 silica gel chromatography Methods 0.000 description 6
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 5
- 229960002895 phenylbutazone Drugs 0.000 description 5
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 206010042220 Stress ulcer Diseases 0.000 description 3
- 150000008366 benzophenones Chemical class 0.000 description 3
- 208000000718 duodenal ulcer Diseases 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical compound OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 125000004149 thio group Chemical group *S* 0.000 description 2
- MBDFDLSVQFDXOV-UHFFFAOYSA-N (3,5-dichloro-2-hydroxyphenyl)-(4-fluorophenyl)methanone Chemical compound OC1=C(Cl)C=C(Cl)C=C1C(=O)C1=CC=C(F)C=C1 MBDFDLSVQFDXOV-UHFFFAOYSA-N 0.000 description 1
- ZNYXYKXCWZHAJS-UHFFFAOYSA-N (4-benzylsulfanylphenyl)-(3,5-dichloro-2-hydroxyphenyl)methanone Chemical compound OC1=C(Cl)C=C(Cl)C=C1C(=O)C(C=C1)=CC=C1SCC1=CC=CC=C1 ZNYXYKXCWZHAJS-UHFFFAOYSA-N 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- UENWRTRMUIOCKN-UHFFFAOYSA-N benzyl thiol Chemical compound SCC1=CC=CC=C1 UENWRTRMUIOCKN-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8609331A FR2600648B1 (fr) | 1986-06-27 | 1986-06-27 | N-imidazolylmethyl-diphenylazomethines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
NO872683D0 NO872683D0 (no) | 1987-06-26 |
NO872683L true NO872683L (no) | 1987-12-28 |
Family
ID=9336786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO872683A NO872683L (no) | 1986-06-27 | 1987-06-26 | Fremgangsmte for fremstilling av difenylazometinderivater |
Country Status (14)
Country | Link |
---|---|
US (1) | US4812467A (pt) |
EP (1) | EP0251858A1 (pt) |
JP (1) | JPS638375A (pt) |
KR (1) | KR880000404A (pt) |
AU (1) | AU591303B2 (pt) |
DK (1) | DK328087A (pt) |
FI (1) | FI872849A (pt) |
FR (1) | FR2600648B1 (pt) |
HU (1) | HU197316B (pt) |
IL (1) | IL82984A0 (pt) |
NO (1) | NO872683L (pt) |
NZ (1) | NZ220852A (pt) |
PT (1) | PT85189A (pt) |
ZA (1) | ZA874642B (pt) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH033615U (pt) * | 1989-06-02 | 1991-01-16 | ||
GB9620202D0 (en) * | 1996-09-27 | 1996-11-13 | Rhone Poulenc Agriculture | New herbicides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2548183B1 (fr) * | 1983-07-01 | 1985-10-31 | Synthelabo | Diphenylazomethines portant un radical imidazolyle, leur preparation et leur application en therapeutique |
-
1986
- 1986-06-27 FR FR8609331A patent/FR2600648B1/fr not_active Expired
-
1987
- 1987-06-17 EP EP87401352A patent/EP0251858A1/fr not_active Withdrawn
- 1987-06-24 IL IL82984A patent/IL82984A0/xx unknown
- 1987-06-26 HU HU872911A patent/HU197316B/hu not_active IP Right Cessation
- 1987-06-26 DK DK328087A patent/DK328087A/da not_active Application Discontinuation
- 1987-06-26 AU AU74771/87A patent/AU591303B2/en not_active Ceased
- 1987-06-26 ZA ZA874642A patent/ZA874642B/xx unknown
- 1987-06-26 NO NO872683A patent/NO872683L/no unknown
- 1987-06-26 US US07/066,531 patent/US4812467A/en not_active Expired - Fee Related
- 1987-06-26 PT PT85189A patent/PT85189A/pt unknown
- 1987-06-26 KR KR1019870006537A patent/KR880000404A/ko not_active Application Discontinuation
- 1987-06-26 NZ NZ220852A patent/NZ220852A/xx unknown
- 1987-06-26 JP JP62160828A patent/JPS638375A/ja active Pending
- 1987-06-26 FI FI872849A patent/FI872849A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI872849A0 (fi) | 1987-06-26 |
FR2600648A1 (fr) | 1987-12-31 |
JPS638375A (ja) | 1988-01-14 |
NO872683D0 (no) | 1987-06-26 |
DK328087A (da) | 1987-12-28 |
AU591303B2 (en) | 1989-11-30 |
KR880000404A (ko) | 1988-03-25 |
HU197316B (en) | 1989-03-28 |
NZ220852A (en) | 1989-07-27 |
FI872849A (fi) | 1987-12-28 |
EP0251858A1 (fr) | 1988-01-07 |
US4812467A (en) | 1989-03-14 |
FR2600648B1 (fr) | 1988-09-09 |
AU7477187A (en) | 1988-01-07 |
DK328087D0 (da) | 1987-06-26 |
HUT45731A (en) | 1988-08-29 |
ZA874642B (en) | 1988-02-24 |
IL82984A0 (en) | 1987-12-20 |
PT85189A (fr) | 1987-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU1181540A3 (ru) | Способ получени сульфамоилзамещенного производного фенэтиламина и его кислотной соли | |
US4675319A (en) | Antianaphylactic and antibronchospastic piperazinyl-(N-substituted phenyl)carboxamides, compositions and use | |
CA1257271A (en) | 6-vinyl-furo-(3,4-c)-pyridine derivatives | |
EP0150255B1 (en) | Pyrrolo[1,2-a]imidazole and imidazo[1,2-a]pyridine immunomodulators | |
EP0029581B1 (en) | Amino substituted tetrahydrobenzindoles, a process for preparing and a pharmaceutical composition containing the same | |
EP0816338B1 (en) | 3-(bis-substituted-phenylmethylene)oxindole derivatives | |
US4134900A (en) | 5,6-Dihydro-4-oxo-4H-thieno[2,3-b]thiopyran-5-carboxamides, and process for the preparation thereof | |
CA1228862A (en) | Azulene derivatives, processes of their synthesis and their uses as anti-ulcerative and anti-inflammatory agents | |
US4127574A (en) | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones | |
US4124587A (en) | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones | |
JP3037991B2 (ja) | 新規なアコニチン系化合物および鎮痛・抗炎症剤 | |
NO872683L (no) | Fremgangsmte for fremstilling av difenylazometinderivater | |
JPS61218571A (ja) | 新規ラクタム誘導体及び新規チオラクタム誘導体並びに抗炎症剤 | |
US4968708A (en) | Imidazo[2,1-B]benzothiazole compounds and antiulcer compositions containing the same | |
JPS63183596A (ja) | グルコシルモラノリン誘導体 | |
US3941788A (en) | Benzimidazole derivatives | |
US4256753A (en) | 4-(2-Pyridylamino)phenylacetic acid derivatives | |
US4076712A (en) | Derivatives of pyrazolo[1,5-a]pyrido[2,3-d]pyrimidin-9(4H)-one | |
US3887585A (en) | Polycyclic gamma-pyrone-3-carboxaldehyde derivatives | |
SU1301315A3 (ru) | Способ получени производных @ -пиразоло /1,5- @ /пиримидина или их солей (его варианты) | |
JP2546841B2 (ja) | 新規なイミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 | |
US4070468A (en) | 2-Amino-quinolin-4-one-3-phosphonic acid esters | |
JPS5810387B2 (ja) | 4,5,6,7テトラヒドロイミダゾ〔4,5−c〕ピリジン誘導体及びその製法 | |
US4124588A (en) | 4-Hydroxy-quinolin-2-one-3-phosphonic acid esters | |
US3985774A (en) | Purification of γ-oxo-2-dibenzofuranbutyric acid |